that scientific criteria are met. Med Uni Graz supports cooperation between science and society in funded projects and also promotes the involvement of children and young people. More information Projects
testing represents an innovative approach to personalized treatment of HCC. Duration: 2025-2028 Funded by: Med Uni Graz Hepatocellular carcinoma – morpho-molecular analysis, digital pathology, and AI [...] and artificial intelligence to advance precision medicine in the field of HCC. Duration: 2025-2028 Funded by: Med Uni Graz Diagnostic and Research Institute of Pathology Ariane Aigelsreiter T: +43 316 385
out whether (endo)cannabinoids have therapeutical value for antitumor therapy. Duration: 2020-2024 Funded by: FWF Project partners: Julia Kargl (Division of Pharmacology, Medical University of Graz); Johannes
in molecular detail and searches for general principles of how they compute. Duration: 2023 – 2028 Funded by: ERC Division of Molecular Biology and Biochemistry Lukas Groschner T: +43 316 385 71968 E: l
last four to eight weeks (depending on department and availability). Clinical rotations/traineeships funded by Erasmus+ must last at least two complete months; eight weeks are not sufficient. Confirmation [...] at the earliest and three workdays after the end of the traineeship at the latest. If your stay is funded by Erasmus+, you also receive a traineeship certificate (part of the learning agreement). Housing [...] at Med Uni Graz even if you are outside of a network. Free mover scholarships are only awarded if funding allocated to network mobility programs remains available. Contact the national CEEPUS office (NCO)
challenge to the health care system. The special research area "Lipid Hydrolysis" funded by the Austrian Science Fund (FWF) is pursuing the long-term goal of discovering the role lipid hydrolases play
influence of a probiotic on vagus nerve functioning in healthy and depressed subjects. Period: Ongoing Funded by: Allergosan, City of Graz NutriMental Screener This study investigates the feasibility of a dietary
opportunity to receive a dedicated study place for tasks in the public interest as part of a study funding program. Information about the dedicated study places Lateral Entry Applicants who are completing
develop and validate novel therapeutic options for pulmonary arterial hypertension. Duration: 2020-2024 Funded by: FWF (I 4651) Project partners: Roxane Paulin (Universitè Laval, Canada/AstraZeneca, Sweden),
Lipid Research , DOI: 10.1016/j.jlr.2023.100491 "Ärzte Aktuell Newsletter" reports about the 2nd funding period of the SFB Lipid Hydrolysis "Ärzte exklusiv Newsletter" of August 2023 informs about the SFB
